Article

Dai , X. and Ahn, K.S. and Wang, L.Z. and Kim, C. and Deivasigamni, A. and Arfuso, F. and Um, J.Y. and Kumar, A.P. and Chang , Y.C. and Kumar, D. and Kundu , G.C. and Magae , J. and Goh, B.C. and Hui , K.M. and Sethi , G. (2016) Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma. Mol Cancer Ther. , 12. pp. 2966-2976.

Mishra , R. and Kumar , D. and Tomar , D. and Chakraborty , G. and Kumar S, Kundu , G.C. and Kundu , G.C. (2015) The potential of class 3 semaphorins as both targets and therapeutics in cancer. Expert Opinion on Therapeutic Targets , 19 (3). pp. 427-442. ISSN 2015 Mar;19(3):427-42

Mishra , R. and Thorat , D. and Soundararajan , G. and Pradhan , S.J. and Chakraborty, G. and Lohite , K. and Karnik , S. and Kundu , G.C. (2015) Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis. Oncogene. pp. 1585-1595.